Benjamin D. Greenbaum

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones

  Cancer Research · 2026-06-22

• Figure S1 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Figure S6 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Figure S4 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Figure S3 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Figure S5 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Table S2 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Table S4 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Table S1 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Table S3 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Figure S7 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Figure S2 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion

  2026-06-17

• Unbiased identification of responding T cell clones from longitudinal repertoire sequencing with CloneSearch

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-01

• Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers

  Nature Communications · 2026-05-21

• Ecological determinants of disease and immunity in myelodysplastic syndromes

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-05-09

• Viral Mimicry by Repeats Mediates Evolutionary Trade-offs in Cancer-Immune Co-Evolution

  Cancer Discovery · 2026-04-17

• Abstract LB423: Invigorating pre-existing tumor-infiltrating expandable (TIE) T cell clonotypes in exceptional responders with dual PARP-PD-1 blockade in homologous recombination deficient (HRD) pancreatic cancer

  Cancer Research · 2026-04-17

• YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination

  Journal of the National Comprehensive Cancer Network · 2026-03-27

• POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-03-17

• How Different are Self and Nonself?

  PRX Life · 2026-01-21 · 1 citations